1. Home
  2. WST vs TEF Comparison

WST vs TEF Comparison

Compare WST & TEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • TEF
  • Stock Information
  • Founded
  • WST 1923
  • TEF 1924
  • Country
  • WST United States
  • TEF Spain
  • Employees
  • WST N/A
  • TEF N/A
  • Industry
  • WST Medical/Dental Instruments
  • TEF Telecommunications Equipment
  • Sector
  • WST Health Care
  • TEF Telecommunications
  • Exchange
  • WST Nasdaq
  • TEF Nasdaq
  • Market Cap
  • WST 15.6B
  • TEF 29.9B
  • IPO Year
  • WST N/A
  • TEF 1987
  • Fundamental
  • Price
  • WST $222.00
  • TEF $5.17
  • Analyst Decision
  • WST Buy
  • TEF
  • Analyst Count
  • WST 7
  • TEF 0
  • Target Price
  • WST $331.67
  • TEF N/A
  • AVG Volume (30 Days)
  • WST 696.4K
  • TEF 561.7K
  • Earning Date
  • WST 07-24-2025
  • TEF 07-30-2025
  • Dividend Yield
  • WST 0.38%
  • TEF 4.46%
  • EPS Growth
  • WST N/A
  • TEF N/A
  • EPS
  • WST 6.37
  • TEF N/A
  • Revenue
  • WST $2,895,800,000.00
  • TEF $44,356,895,792.00
  • Revenue This Year
  • WST $3.38
  • TEF N/A
  • Revenue Next Year
  • WST $5.85
  • TEF $0.17
  • P/E Ratio
  • WST $34.87
  • TEF N/A
  • Revenue Growth
  • WST N/A
  • TEF 0.72
  • 52 Week Low
  • WST $187.43
  • TEF $3.89
  • 52 Week High
  • WST $352.33
  • TEF $5.48
  • Technical
  • Relative Strength Index (RSI)
  • WST 55.47
  • TEF 55.29
  • Support Level
  • WST $215.67
  • TEF $5.17
  • Resistance Level
  • WST $226.80
  • TEF $5.33
  • Average True Range (ATR)
  • WST 5.26
  • TEF 0.05
  • MACD
  • WST -0.05
  • TEF -0.00
  • Stochastic Oscillator
  • WST 65.84
  • TEF 42.42

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About TEF Telefonica SA

Telefonica operates mobile and fixed networks in Spain (where it is the incumbent operator), the UK, Germany, Brazil, and Latin American countries. The company derives more than 30% of its revenue from Spain, close to 20% from Germany, and 20% from Brazil. Its UK operations are held through a joint venture with Virgin Media. For several years Telefonica has been simplifying its corporate structure by selling noncore assets.

Share on Social Networks: